How We Work

Grant

Back

Print

General Hospital Corporation


October 2012
to develop a microfluidic device that can be used to screen anti-malarial drugs for the development of drug resistance with single cell resolution.
$100,000
19
Discovery and Translational Sciences
Global Health
Boston, Massachusetts
http://www.massgeneral.org/

Visit Our Blog